Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc (NOVT) delivers precision photonic components and motion-control systems powering innovations in medical technology and industrial automation. This dedicated news hub provides investors and industry professionals with direct access to official press releases and verified updates about the company's technological advancements.
Discover comprehensive coverage of Novanta's latest developments including product launches for minimally invasive surgery tools, strategic partnerships in robotics, and innovations in laser-based manufacturing systems. Our curated feed ensures you stay informed about earnings announcements, leadership updates, and patent filings that demonstrate NOVT's leadership in mission-critical OEM solutions.
Key updates focus on the company's Medical Solutions segment enhancing surgical workflows and Automation Enabling Technologies driving smart manufacturing. Track progress in RFID-based hospital systems and high-precision components for additive manufacturing – all critical to Novanta's dual-market strategy.
Bookmark this page for streamlined access to NOVT's evolving role in medical device innovation and industrial automation. Check regularly for authoritative updates on photonics advancements and motion-control technologies shaping next-generation healthcare and manufacturing ecosystems.
Novanta Inc. (NASDAQ: NOVT) has announced an agreement to acquire Schneider Electric Motion USA for $115 million in cash, with an expected close in the third quarter of 2021. SEM specializes in motion control components for automation, enhancing Novanta's capabilities in robotics and medical technology. This acquisition aligns with Novanta's strategy to expand its precision motion control portfolio and increase exposure to Life Sciences and Medical markets. The deal is projected to be accretive to Novanta's free cash flow and non-GAAP earnings per share.
Novanta Inc. (Nasdaq:NOVT), a trusted partner to medical and advanced technology manufacturers, announced that CFO Robert Buckley will present at the 21st Annual CJS Securities New Ideas Summer Conference on July 13, 2021. The conference will be held virtually.
About Novanta: Novanta is a leading global supplier of core technology solutions, specializing in photonics, vision, and precision motion. The company provides engineered components and sub-systems designed for extreme precision and performance, catering to the demands of OEMs in medical and industrial sectors.
Novanta Inc. (Nasdaq: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at Baird's 2021 Global Consumer, Technology & Services Conference on June 8, 2021. This virtual event showcases Novanta's role as a key technology partner for medical and advanced technology OEMs, emphasizing its expertise in photonics, vision, and precision motion. The company's innovative professionals are committed to delivering high-performance solutions tailored to customer needs, positioning Novanta as a leader in core technology solutions.
Novanta Inc. (Nasdaq: NOVT), a technology partner for medical and advanced technology equipment manufacturers, announced that CEO Matthijs Glastra and CFO Robert Buckley will present at William Blair's 41st Annual Growth Stock Conference on May 26, 2021. This virtual event highlights Novanta's role as a leading global supplier of technology solutions, focusing on photonics, vision, and precision motion for OEMs. The company's commitment to innovation and customer success drives its growth. More details are available at www.novanta.com.
Novanta reported Q1 2021 revenues of $162.6 million, a 4.6% increase year-over-year. Operating income declined to $11.1 million from $13.3 million, with net income at $11.3 million compared to $11.9 million in Q1 2020. Adjusted diluted EPS rose to $0.58 from $0.51. The company noted a 28% increase in bookings sequentially and 25% year-over-year, driven by strong demand in advanced industrial sectors. Guidance for Q2 forecasts revenue of $162 million to $165 million and for the full year expects revenue between $645 million to $655 million.
Novanta Inc. (Nasdaq: NOVT) will announce its Q1 2021 results on May 11, 2021, at 10:00 a.m. ET. Investors can join the conference call by dialing (888) 346-3959 or via a live webcast on the Company’s website. A replay of the call will be available approximately three hours post-call until July 5, 2021. Novanta is a global leader in core technology solutions, specializing in photonics, vision, and precision motion, aimed at enhancing the performance of healthcare and industrial OEMs.
Novanta Inc. (NASDAQ: NOVT) has announced that Matthijs Glastra will take on the role of Chairman of the Board effective after the Annual Meeting on May 13, 2021. He succeeds Stephen W. Bershad, who retires after 11 years of impactful leadership. Also, Lonny Carpenter will become the independent Lead Director. In recognition of Bershad’s contributions, he will be appointed Chairman Emeritus. Glastra noted that the company is well-positioned for sustained growth, despite challenges posed by the COVID-19 pandemic.
Novanta reported Q4 and full year 2020 results, highlighting revenue of $147.5 million, down 7.6% year-over-year. For the full year, revenue declined 5.7% to $590.6 million. Despite a decrease in organic growth of 10.1% for Q4, operating income rose to $17.1 million, and net income reached $12.7 million. Adjusted diluted EPS for Q4 was $0.53, slightly down from $0.55. The company forecasts Q1 2021 revenue of $155 million to $157 million and plans to launch significantly more new products. Operating cash flow remained strong at $46.6 million for Q4.
Novanta Inc. (Nasdaq: NOVT) will announce its fourth quarter and full year 2020 results on March 1, 2021. A conference call is scheduled for the same day at 10:00 a.m. ET, accessible via phone or through a live webcast on the Company's website. A replay of the call will be available approximately three hours after its conclusion, lasting until April 5, 2021. Novanta is a global supplier of advanced technology solutions that provide OEMs in healthcare and industrial sectors with a competitive edge through precision and technical expertise.
FAQ
What is the current stock price of Novanta (NOVT)?
What is the market cap of Novanta (NOVT)?
